Multiple reaction monitoring mass spectrometry to identify novel plasma protein biomarkers of treatment response in cystic fibrosis pulmonary exacerbations
Systemic inflammation decreases with IV antibiotics during the treatment of CF pulmonary exacerbations (PEx). We used multiple reaction monitoring mass spectrometry and immunoassays to monitor blood proteins during PEx treatment to determine if early changes could be used to predict PEx outcomes following treatment.
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: James M. Roberts, Darlene L.Y. Dai, Zsuzsanna Hollander, Raymond T. Ng, Scott J. Tebbutt, Pearce G. Wilcox, Don D. Sin, Bradley S. Quon Tags: Original Article Source Type: research
More News: Cystic Fibrosis | Respiratory Medicine